Explained: What phase 3 data says on Bharat Biotech’s Covaxin vaccine – The Indian Express
Covaxin, the vaccine manufactured by Bharat Biotech, has demonstrated overall interim clinical efficacy of 78 per cent, and 100 per cent efficacy against severe Covid-19 disease in phase 3 trials, …
